Analog Devices Appoints Dr. Laurie H. Glimcher to Board of Directors
August 18 2020 - 5:30PM
Business Wire
Analog Devices, Inc. (NASDAQ: ADI) today announced the
appointment of Dr. Laurie H. Glimcher, MD, to the Board of
Directors as an independent director, effective immediately. Dr.
Glimcher is currently a Professor of Medicine at Harvard Medical
School and the President and Chief Executive Officer of the
Dana-Farber Cancer Institute.
Dr. Glimcher’s appointment expands the Board to 11 directors,
nine of whom are independent. She will be a member of the Board’s
Compensation Committee.
“We are excited to have Laurie join the ADI Board as we continue
to invest and develop innovative healthcare solutions for our
customers,” said Ray Stata, ADI Chairman of the Board. “Laurie is a
distinguished immunologist with extensive experience working in
both private and public settings to advance research, medical
education and health policy. In addition, Laurie is a pioneering
mentor and strong advocate promoting women’s role in science. The
insights she has gained over her medical career will be of great
benefit to ADI as we aim to accelerate the growth of our healthcare
business.”
Dr. Glimcher speaks nationally and internationally on cancer,
immunology, skeletal biology, and translational medicine, and has
contributed more than 350 scholarly articles and papers to the
medical literature. She also currently serves on the Board of
Directors at GlaxoSmithKline Pharmaceutical Corporation.
In addition to a number of senior leadership roles held at both
Harvard Medical School and Harvard School of Public Health from
1982 to present, she has also served as the Stephen and Suzanne
Weiss Dean and Professor of Medicine of Weill Cornell Medicine and
Provost for Medical Affairs of Cornell University. She is a member
of the Board of Trustees at the Dana-Farber Cancer Institute and a
member of the US National Academy of Sciences, the National Academy
of Medicine, the American Academy of Arts and Sciences and the
American Philosophical Society. She previously served on the Board
of Directors of Bristol-Myers Squibb Pharmaceutical Corporation and
Waters Corporation.
She is also the recipient of many awards and honors. In 2018,
she received the American Association of Immunologists Lifetime
Achievement Award; the Indiana University School of Medicine's
Steven C. Beering Award for outstanding research contributions to
advancement of biomedical or clinical science; and the
L'Oréal-UNESCO Award for Women in Science. She has also received
the 2017 George M. Kober Medal and the 2017 Award for Distinguished
Research in the Biomedical Sciences from the Association of
American Medical Colleges (AAMC).
Dr. Glimcher is a magna cum laude graduate of Radcliffe College,
and holds an MD degree cum laude from Harvard Medical School.
About Analog Devices
Analog Devices (Nasdaq: ADI) is a leading global
high-performance analog technology company dedicated to solving the
toughest engineering challenges. We enable our customers to
interpret the world around us by intelligently bridging the
physical and digital with unmatched technologies that sense,
measure, power, connect and interpret. Visit
http://www.analog.com.
(ADI-WEB)
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200818005776/en/
Analog Devices, Inc. Mr. Michael Lucarelli Sr. Director of
Investor Relations 781-461-3282 investor.relations@analog.com
Analog Devices (NASDAQ:ADI)
Historical Stock Chart
From Mar 2024 to Apr 2024
Analog Devices (NASDAQ:ADI)
Historical Stock Chart
From Apr 2023 to Apr 2024